A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age
GlaxoSmithKline
GlaxoSmithKline
University College, London
National Institutes of Health Clinical Center (CC)
University of Maryland, Baltimore
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)